All News #Library
Rare Diseases
Ema Designates Bexobrutideg for Waldenström Macroglobulinemia
07 Jul 2025 //
GLOBENEWSWIRE
Nurix`s Bexobrutideg (NX-5948) Granted FDA Orphan Drug Designation
17 Mar 2025 //
GLOBENEWSWIRE
Nurix Announces Appointment of Stefani A. Wolff as COO
21 Jun 2021 //
GLOBENEWSWIRE

Market Place
Sourcing Support